Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Eiko Nishinaka"'
Autor:
Toshihiro Kurahashi, Chiyoko Nishime, Eiko Nishinaka, Yuji Komaki, Fumiko Seki, Koji Urano, Yoshinori Harada, Toshikazu Yoshikawa, Ping Dai
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 18, p 13853 (2023)
The development of regenerative medicine using cell therapy is eagerly awaited for diseases such as spinal cord injury (SCI), for which there has been no radical cure. We previously reported the direct conversion of human fibroblasts into neuronal-li
Externí odkaz:
https://doaj.org/article/c560e4cea403467fb03ab6951ef5f6d3
Autor:
Riichi Takahashi, Jochen Welcker, Yuyo Ka, Kayo Tomiyama, Misa Mochizuki, Ryoji Ito, Taichi Yamamoto, Tomoyuki Ogura, Motohito Goto, Mamoru Ito, Kenji Kawai, Ikumi Katano, Eiko Nishinaka
Publikováno v:
Immunology Letters. 229:55-61
Humanized mice are widely used to study the human immune system in vivo and develop therapies for various human diseases. Human peripheral blood mononuclear cells (PBMC)-engrafted NOD/Shi-scid IL2rγnull (NOG) mice are useful models for characterizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49958c87cac112f390ed0e4a72627787
https://doi.org/10.1016/j.imlet.2020.11.011
https://doi.org/10.1016/j.imlet.2020.11.011
Autor:
Ryoji Ito, Ikumi Katano, Immanuel W.H. Kwok, Lai Guan Ng, Miyuki Ida-Tanaka, Yusuke Ohno, Yunmei Mu, Hanako Morita, Eiko Nishinaka, Chiyoko Nishime, Misa Mochizuki, Kenji Kawai, Tay Hui Chien, Zhao Yunqian, Fan Yiping, Liew Hui Hua, Teja Celhar, Jerry Kok Yen Chan, Takeshi Takahashi, Motohito Goto, Tomoyuki Ogura, Riichi Takahashi, Mamoru Ito
Publikováno v:
Cell Reports. 41:111841
Neutrophils are critical mediators during the early stages of innate inflammation in response to bacterial or fungal infections. A human hematopoietic system reconstituted in humanized mice aids in the study of human hematology and immunology. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186b4f2c55686d3db09d567e0d07d031
https://doi.org/10.1016/j.celrep.2022.111841
https://doi.org/10.1016/j.celrep.2022.111841
Autor:
Takako Hiyoshi1,2 hiyoshit@ciea.or.jp, Chiyoko Nishime1, Eiko Nishinaka1, Fumiko Seki3, Kenji Kawai1, Misa Mochizuki1, Koji Urano1, Toshio Imai1, Taichi Yamamoto1, Masami Suzuki1
Publikováno v:
Journal of Toxicologic Pathology. 2024, Vol. 37 Issue 2, p93-97. 5p.
Autor:
Kiyoshi Ando, Chiyoko Nishime, Kenji Kawai, Ryo Inoue, Koji Urano, Hideki Tsutsumi, Eiko Nishinaka
Publikováno v:
Behavioural Pharmacology
The differential effects of dopaminergic drugs with different pharmacological profiles were investigated with respect to spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine (6-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1b1d3e6f5d9d6b5bcc56747d688c52
https://doi.org/10.1097/fbp.0000000000000353
https://doi.org/10.1097/fbp.0000000000000353
Autor:
Kiyoshi Ando, Chiyoko Nishime, Keigo Hikishima, Yuji Komaki, Takashi Inoue, Eiko Nishinaka, Kenji Kawai, Ryo Inoue, Koji Urano, Hideyuki Okano
Publikováno v:
Behavioural Pharmacology
Supplemental Digital Content is available in the text.
Baseline locomotion and behavioral traits in the common marmoset Parkinson's disease model were examined to provide basic information for preclinical evaluations of medical treatments. A sin
Baseline locomotion and behavioral traits in the common marmoset Parkinson's disease model were examined to provide basic information for preclinical evaluations of medical treatments. A sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a87e0f36721e7ed277716c2814f80c
https://pubmed.ncbi.nlm.nih.gov/31625972
https://pubmed.ncbi.nlm.nih.gov/31625972
Autor:
Chiyoko Nishime, Taichi Yamamoto, Ryoji Ito, Ikumi Katano, Eiko Nishinaka, Kenji Kawai, Jun-ichi Hata
Publikováno v:
Cancer Research. 78:LB-278
Within the past decade, immune checkpoint inhibitors, such as anti-programmed death (PD)-1 antibodies (e.g. pembrolizumab; Keytruda and Nivolumab: OPDIVO), treatment has become one of the most advancing therapeutic options in oncology. The PD-1/PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bb833bcbb0d518a22e324a0d26a84cc
https://doi.org/10.1158/1538-7445.am2018-lb-278
https://doi.org/10.1158/1538-7445.am2018-lb-278
Autor:
Koji Urano, R. Inoue, T. Mizushima, Rumi Sawada, Satoshi Yasuda, Yoji Sato, Hideki Tsutsumi, Eiko Nishinaka, Shinji Kusakawa
Publikováno v:
Toxicology Letters. 238:S365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::977cbae4c700888ae826e5e3a425fc26
https://doi.org/10.1016/j.toxlet.2015.08.1042
https://doi.org/10.1016/j.toxlet.2015.08.1042
Autor:
M. Tomizawa, Eiko Nishinaka, Kazuhiko Machida, Koji Urano, Tomoyuki Ogura, Hideki Tsutsumi, Masahiko Yasuda, K. Ito
Publikováno v:
Toxicology Letters. 205:S82-S83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2257eb300819931c6a73209cf88ddd8c
https://doi.org/10.1016/j.toxlet.2011.05.306
https://doi.org/10.1016/j.toxlet.2011.05.306
Autor:
Kurahashi, Toshihiro1 (AUTHOR) kurahasi@koto.kpu-ma.ac.jp, Nishime, Chiyoko2 (AUTHOR) nishime@ciea.or.jp, Nishinaka, Eiko2 (AUTHOR) nishinaka@ciea.or.jp, Komaki, Yuji2 (AUTHOR) komaki@ciea.or.jp, Seki, Fumiko2 (AUTHOR) fumiko@ciea.or.jp, Urano, Koji2 (AUTHOR) urano@ciea.or.jp, Harada, Yoshinori3 (AUTHOR) yoharada@koto.kpu-m.ac.jp, Yoshikawa, Toshikazu1,4 (AUTHOR) yoshi@koto.kpu-m.ac.jp, Dai, Ping1 (AUTHOR) dping@koto.kpu-m.ac.jp
Publikováno v:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p13853. 21p.